Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

HeMemics Biotechnologies

HeMemics Biotechnologies
PRIVATE STATUS
Angel LATEST DEAL TYPE
$777K LATEST DEAL AMOUNT
4 INVESTORS
Description

Developer of a preservation platform designed to leverage precision medicine that predict, prevent and treat diseases. The company's platform is designed to preserve mammalian cells and biologics in desiccated and non-desiccated formats in cold or ambient temperature instead of frozen format, enabling individuals to live longer, healthier lives.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Primary Office
  • 9700 Great Seneca Highway
  • Rockville, MD 20850
  • United States

+1 (301) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore HeMemics Biotechnologies’s full profile, request a free trial.

HeMemics Biotechnologies Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Angel (individual) 25-May-2018 $777K 00000 Completed Startup
3. Accelerator/Incubator 01-Dec-2017 00000 Completed Startup
2. Grant 01-Jan-2012 $185K $107K Completed Startup
1. Accelerator/Incubator 13-Aug-2007 $107K $107K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

HeMemics Biotechnologies Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Inova Personalized Health Accelerator Accelerator/Incubator Minority 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
Maryland Industrial Partnerships Accelerator/Incubator Minority 000 0000 000000 0
TEDCO Venture Capital Minority 000 0000 000000 0

HeMemics Biotechnologies Executive Team (6)

Name Title Board
Seat
Contact
Info
Bruce Campbell President & Board Member
John Warden Chief Operating Officer
David Ho Ph.D Chief Executive Officer, Chief Scientific Officer & Board Member
James Hogarty Executive Officer & Board Member
Roger Brook Executive Officer & Board Member
You’re viewing 5 of 6 executives. Get the full list »

HeMemics Biotechnologies Board Members (6)

Name Representing Role Since Contact
Info
Bruce Campbell HeMemics Biotechnologies President & Board Member 000 0000
David Ho Ph.D HeMemics Biotechnologies Chief Executive Officer, Chief Scientific Officer & Board Member 000 0000
James Hogarty HeMemics Biotechnologies Executive Officer & Board Member 000 0000
Larry Hogarty HeMemics Biotechnologies Board Member 000 0000
Roger Brook HeMemics Biotechnologies Executive Officer & Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »